Abstract: A method for preparing an ester bleach activator compound is disclosed. The method includes (A) preparing fatty acid monoester; (B) making chloroformate by reacting the fatty acid monoester with at least one selected from the group consisting of phosgene, diphosgene and triphosgene in the presence of base; and (C) reacting the chloroformate with hydroxybenzene, its derivatives, or its salts in solvent. According to the method, the ester bleach activator compound can be made in a simple and economic way.

Abstract: The present invention relates to a skin aging treatment comprising paeoniflorin as an active ingredient. Since paeoniflorin is effective in significantly inhibiting and improving intrinsic skin aging, significantly inhibiting and improving DNA impairment and skin wrinkling caused by UV and improving existing wrinkles, a cosmetic composition and a pharmaceutical composition comprising paeoniflorin may become a very useful skin aging treatments.

Abstract: A method for preparing an ester bleach activator compound is disclosed. The method includes (A) preparing fatty acid monoester; (B) making chloroformate by reacting the fatty acid monoester with at least one selected from the group consisting of phosgene, diphosgene and triphosgene in the presence of base; and (C) reacting the chloroformate with hydroxybenzene, its derivatives, or its salts in solvent. According to the method, the ester bleach activator compound can be made in a simple and economic way.

Abstract: The present invention relates to a skin aging treatment comprising paeoniflorin as an active ingredient. Since paeoniflorin is effective in significantly inhibiting and improving intrinsic skin aging, significantly inhibiting and improving DNA impairment and skin wrinkling caused by UV and improving existing wrinkles, a cosmetic composition and a pharmaceutical composition comprising paeoniflorin may become a very useful skin aging treatments.

Abstract: The present invention relates to a fusion peptide, in which a self cell-penetrating Tat peptide having a self penetrating signal is bound to a human Type-I collagen C-terminal derived peptide, a preparation thereof, and a skin anti-aging cosmetic composition comprising the same. Since the fusion peptide, in which the Tat peptide is bound to the human Type-collagen C-terminal derived peptide is highly stable and has a superior skin absorption capability, the present invention provides a skin anti-aging agent having superior synthesis of collagen and hyaluronic acid, anti-aging effects, and improved durability of the effects.

Abstract: The present invention relates to a fusion peptide wherein a self cell-penetrating Tat peptide having a self penetrating signal is bound to a human parathyroid hormone-derived peptide, a preparation thereof, and a skin slimming cosmetic composition comprising the same. Since the fusion peptide wherein the Tat peptide is bound to the human parathyroid hormone-derived peptide has high stability and superior skin absorption, the present invention provides a skin slimming agent having superior lipolysis effects and improved durability of the effects.

Abstract: The present invention relates to a fusion peptide wherein a self cell-penetrating Tat peptide having a self penetrating signal is bound to a human parathyroid hormone-derived peptide, a preparation thereof, and a skin slimming cosmetic composition comprising the same. Since the fusion peptide wherein the Tat peptide is bound to the human parathyroid hormone-derived peptide has high stability and superior skin absorption, the present invention provides a skin slimming agent having superior lipolysis effects and improved durability of the effects.

Abstract: The present invention relates to a fusion peptide, in which a self cell-penetrating Tat peptide having a self penetrating signal is bound to a human Type-I collagen C-terminal derived peptide, a preparation thereof, and a skin anti-aging cosmetic composition comprising the same. Since the fusion peptide, in which the Tat peptide is bound to the human Type-I collagen C-terminal derived peptide is highly stable and has a superior skin absorption capability, the present invention provides a skin anti-aging agent having superior synthesis of collagen and hyaluronic acid, anti-aging effects, and improved durability of the effects.

Abstract: A cosmetic composition for preventing and treating acne, contains cryptotanshinone as an effective component. The cosmetic composition containing cryptotanshinone can be safely used without any side effect on skin, and further, can very effectively control the amount of sebum secretion due to inhibition of 5 &agr;-reductase activation, and has superior anti-bacterial and anti-inflammation ability.

Abstract: Provided with a novel ascorbic acid derivative represented by the formula (I) and a method for preparing the same: wherein R1 and R2 are different from each other and, independently H or —CH2CH2—(O—CH2—CH2)n—OR3, wherein n is an integer from 2 to 400; and R3 is a lower alkyl group having 1 to 10 carbon atoms. The novel ascorbic acid derivatives of this invention have excellent characteristics such as long-lasting anti-oxidation effect, high solubility in both water and organic solvents, and high stability in an aqueous solution. Furthermore, the novel ascorbic acid derivatives are useful for feed, food, cosmetic and pharmaceutical products due to their low toxicity and high thermal stability.

Abstract: The present invention relates to a polyethoxylated retinamide derivative represented by formula (I), which is useful as an agent for inhibiting skin aging; in R represents hydrogen or C1-6 lower alkyl and n denotes the number of 2 to 100, and the process for preparing the compound of formula (I) as an effective component.